1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 16 MARCH 2015

CNS Drug News 16 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Costs Of Treating MS To Rise In US
Industry Brief - Acadia Delays Nuplazid NDA Submission; Appoints Interim CEO
Industry Brief - Cynapsus To Initiate APL-130277 Phase III Programme In Q215
Industry Brief - Pharma Two B Completes Enrolment In P2B001 Phase IIb Study For PD
Industry Brief - Consilient Launches Pramipexole In UK
Industry Brief - AGB101 Restores Brain Network Function/Improves Memory In Elderly With aMCI
Industry Brief - Neurotrope Reports Positive Final Results From Bryostatin-1 Phase IIa Safety Study For AD
Industry Brief - First Patient Enrolled In Phase IIa Study Of Probiodrug's PQ912 For AD
Industry Brief - Opexa Amends Agreement With Merck Serono For Tcelna In MS
Industry Brief - Isis Earns Milestone For Advancing ISIS-SMNRx In Infants With SMA
Industry Brief - FDA Approves Lower Therapeutic Dose Of Viibryd
Industry Brief - CHMP Issues Positive Opinion For Brintellix Label Update
Industry Brief - Denovo Licenses Pomaglumetad From Lilly For Development As Personalised Medicine
Industry Brief - FDA Approves Saphris As MT For Paediatric Patients With Bipolar I Disorder
Industry Brief - Alcobra's Phase II Study Of MDX In Adolescents With ADHD Meets Primary Endpoint
Industry Brief - Highland Announces US Patent Allowance; Provides Amphetamine Development Update
Industry Brief - FDA Cancels Advisory Committee Meeting On Merck's Sugammadex; CRL Expected
Industry Brief - Mylan Launches Fentanyl Intermediate Dosage Strengths
Industry Brief - AcelRx Initiates ARX-04 Phase III Trial In Moderate-To-Severe Acute Pain
Industry Brief - Egalet Accelerates Development Of Abuse-Deterrent Morphine; Plans To File NDA In Q415
Industry Brief - Orexo US Launches New Zubsolv Dosage Strength
Industry Brief - Mylan Launches Disulfiram In US
Industry Brief - Mylan Launches Buprenorphine In US
Industry Trend Analysis - Controversial Data Suggest Advantage For Contrave In Obesity Market
Industry Trend Analysis - Sale Of Zohydro ER Business Will Raise Capital And Reduce Costs For Zogenix
Industry Brief - Sun Pharma To Buy GSK's Opiates Business In Australia
Industry Brief - Collegium Raises Funds To Support Commerical Development Of Abuse-Deterrent Xtampza ER
Industry Brief - Parkure Gets Crowdfunding Investment To Develop PD Cure
Industry Brief - CNS Conferences - June 2015

Table Of Contents

CNS Drug News 16 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.